SEC Tracker
Get the app

AngioDynamics ANGO

Eric Honroth (CEO) received 101,193 ANGO

Form
4
Filed
Importance
Routine
  1. Eric Honroth acquired 62,928 common shares on Nov 2, 2026
  2. Eric Honroth acquired 38,265 common shares on Nov 2, 2026
  3. Performance rights tied to revenue, EBITDA, and TSR metrics

Written from the Form 4 on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when AngioDynamics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 3841 and related industry codes: the same peer list as the financial tables.

  1. Orthofix Medical OFIX public float $440M, Jun 30, 2025
  2. Axogen AXGN public float $431M, Jun 30, 2025
  3. Delcath Systems DCTH public float $420M, Jun 30, 2025
  4. Ceribell CBLL public float $417M, Jun 30, 2025
  5. Iradimed IRMD public float $481M, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.